Status:
COMPLETED
Effect of Dexmedetomidine on Parturient Undergoing Elective Cesarean Section.
Lead Sponsor:
The Affiliated Hospital of Xuzhou Medical University
Conditions:
Cesarean Section
Eligibility:
FEMALE
20-40 years
Phase:
PHASE4
Brief Summary
The purpose of this study was to investigate whether dexmedetomidine used in the perioperative period of elective cesarean section can improve maternal mood, improve analgesic effect, improve maternal...
Detailed Description
After obtaining the informed consent, parturients were randomly divided into two groups according to the computer-generated random number table, namely, dexmedetomidine group and the control group.Spi...
Eligibility Criteria
Inclusion
- ASA class I or II
- BMI≦35kg/m2
- Greater than 37 weeks gestation
- Expressed a desire to breastfeed for a least 3 months postpartum
- Elective cesarean section
Exclusion
- Intraspinal anesthesia contraindication
- Twin or fetal Intrauterine distress
- Preoperative history of application of analgesia or sedative drug
- Severe cardiac and pulmonary dysfunction
- History of neurological and psychiatric diseases
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 2 2019
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03805945
Start Date
June 1 2019
End Date
December 2 2019
Last Update
December 3 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China, 221000